Ethics approval and consent to participate
The study was permitted by the Law of the People’s Republic of China on the Protection of Wildlife, and the protocol was approved by the Institutional Animal Care Committee of Shanghai University of medicine & Health Sciences, China (Permit Number: JCLW01-08).
References:
  1. Frangogiannis NG. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med. 2019;65:70-99.
  2. Blythe NM, Muraki K, Ludlow MJ, et al. Mechanically activated Piezo1 channels of cardiac fibroblasts stimulate p38 mitogen-activated protein kinase activity and interleukin-6 secretion. J Biol Chem. 2019; 294(46): 17395-17408.
  3. Cook SA, Schafer S. Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation.Annu Rev Med. 2020 Jan 27;71:263-276. [5] Rios FJ, Zou ZG, Harvey AP, et al. Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis. Cardiovasc Res. 20201; 116(3): 721-735. [6] Jung M, Ma Y, Iyer RP, et al. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol. 2017; 112(3): 33:1-24. [7] Pseftogas A, Gonidas C, Mosialos G. Activation of peroxisome proliferator-activated receptor gamma in mammary epithelial cells upregulates the expression of tumor suppressor Cyld to mediate growth inhibition and anti-inflammatory effects. Int J Biochem Cell Biol. 2017; 82: 49-56. [8] Thangaiyan R, Arjunan S, Govindasamy K,et al. Galangin Attenuates Isoproterenol-Induced Inflammation and Fibrosis in the Cardiac Tissue of Albino Wistar Rats. Front Pharmacol. 2020; 30;11: 585163. [9] Kökény G, Calvier L, Legchenko E, et al. PPARgamma is a gatekeeper for extracellular matrix and vascular cell homeostasis: beneficial role in pulmonary hypertension and renal/cardiac/pulmonary fibrosis. Curr Opin Nephrol Hypertens. 2020; 29(2): 171-179. [10] Ghosh RK, Banerjee K, Tummala R, et al. Serelaxin in acute heart failure: Most recent update on clinical and preclinical evidence. Cardiovasc Ther. 2017; 35(1): 55-63. [11] Tan J, Tedrow JR, Dutta JA, et al. Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies. Am J Respir Crit Care Med. 2016; 194(11): 1392-1402. [12]Wang C, Pinar AA, Widdop RE, et al.The anti-fibrotic actions of relaxin are mediated through AT(2) R-associated protein phosphatases via RXFP1-AT(2) R functional crosstalk in human cardiac myofibroblasts. FASEB J. 2020; 34(6): 8217-8233. [13] Pinar AA, Yuferov A, Gaspari TA, et al. Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1. Front Pharmacol. 2020; 11: 1201 [14] Bennett RG, Simpson RL, Hamel FG. Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis. World J Gastroenterol. 2017; 23(22): 3999-4006.
  1. Bolívar S, Anfossi R, Humeres C, et al. IFN-beta Plays Both Pro- and Anti-inflammatory Roles in the Rat Cardiac Fibroblast Through Differential STAT Protein Activation. Front Pharmacol. 2018; 9: 1368.
  2. Emming S, Bianchi N, Polletti S, et al.A molecular network regulating the proinflammatory phenotype of human memory T lymphocytes. Nat Immunol. 2020; 21(4): 388-399.
  3. Felisbino MB, McKinsey TA. Epigenetics in Cardiac Fibrosis: Emphasis on Inflammation and Fibroblast Activation. JACC Basic Transl Sci. 2018; 12;3(5):704-715.
  4. Sager HB, Heidt T, Hulsmans M, Dutta P, Courties G, Sebas M, et al. Targeting interleukin-1beta reduces leukocyte production after acute myocardial infarction. Circulation. (2015) 132:1880–1890.
  5. Abbate A, Trankle CR, Buckley LF, et al. Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction. J Am Heart Assoc. 2020; 9(5):e014941.
[20] Scott L Jr, Li N, Dobrev D. Role of inflammatory signaling in atrial fibrillation. Int J Cardiol. 2019; 287:195-200.
[21]Bansal SS, Ismahil MA, Goel M, et al. Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy. Circulation. 2019;139(2):206-221.
[22] Zhao L, Cheng G, Jin R, et al. Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction. Circ Res. 2016;118(12):1918-1929.
[23]Collino M, Rogazzo M, Pini A, et al. Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury. J Cell Mol Med. 2013;17(11): 1494-505.
[24]Heo YJ, Choi SE, Jeon JY, et al. Visfatin Induces Inflammation and Insulin Resistance via the NF-kappaB and STAT3 Signaling Pathways in Hepatocytes. J Diabetes Res. 2019; 2019: 4021623.
[25] Ranjan P, Kumari R, Verma SK. Cardiac Fibroblasts and Cardiac Fibrosis: Precise Role of Exosomes. Front Cell Dev Biol. 2019;7:318.
[26] Jung M, Ma Y, Iyer RP,et al. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation.Basic Res Cardiol. 2017 May;112(3):33
[27] Lee AS, Jung YJ, Thanh TN, et al. Paricalcitol attenuates lipopolysaccharide-induced myocardial inflammation by regulating the NF-kappaB signaling pathway. Int J Mol Med. 2016;37(4):1023-9.
[28] Vetuschi A, Pompili S, Gaudio E, et al. PPAR-gamma with its anti-inflammatory and anti-fibrotic action could be an effective therapeutic target in IBD. Eur Rev Med Pharmacol Sci. 2018; 22(24): 8839-8848.
[29] Bennett RG, Simpson RL,Hamel FG Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis. World J Gastroenterol.. 2017; 23(22): 3999-4006.
[30] Elkahloun AG, Rodriguez Y, Alaiyed S, et al. Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPARgamma Activation. Mol Neurobiol. 2019;56(5):3193-3210.
[31] Zhang Y.-F., Zou X.-L., Wu J., Yu X.-Q., Yang X. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-gamma Agonist, Attenuates Inflammation Via NF-kappa B Inhibition in Lipopolysaccharide-Induced Peritonitis. Inflammation. 2015;38(6):2105–2115.
Legend